Have a personal or library account? Click to login
The improvement of treatment efficacy of gastropathy associated with the use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-negative patients with osteoarthritis Cover

The improvement of treatment efficacy of gastropathy associated with the use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-negative patients with osteoarthritis

Open Access
|Mar 2015

References

  1. 1. Fossmark R., Johnsen G., Johanessen E.: Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther., 21, 2, 2005.
  2. 2. Lam E. et al.: Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG. Life Sci., 80, 2007.10.1016/j.lfs.2007.03.01817499310
  3. 3. Muratoglu G. et al.: Protective effect of famotidine, omeprazole and melatonin against acetylsalicytic acid-induced gastric damage in rats. Dig Dis Sci., 46, 2001.
  4. 4. Senol A. et al. Effect of probiotics on aspirin-induced gastric mucosal lesions. Turk J Gastroenterol., 22, 1, 2011.10.4318/tjg.2011.015121480106
  5. 5. Syer S, Wallace J. Environmental and NSAID-enteropathy: dysbiosis as a common factor. Curr Gastroenterol Rep., 16, 201410.1007/s11894-014-0377-124532193
  6. 6. Wallace J. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol., 165, 2012.10.1111/j.1476-5381.2011.01509.x325296721627632
DOI: https://doi.org/10.1515/cipms-2015-0023 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 237 - 239
Submitted on: Nov 7, 2014
|
Accepted on: Dec 12, 2014
|
Published on: Mar 3, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2015 Antonina V. Antonenko, Tetyana V. Beregova, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.